Synapse - Maura Dickler

Results (263)

Improvement in sexual function over time in premenopausal women with breast cancer

Meeting Abstract

Goldfarb, S. B.; Kamer, S.; Baser, R.; Quistorff, J.; Gemignani, M. L.; Dickler, M.
Cancer Research (2018)

Breast carcinoma with 21-gene recurrence score lower than 18: Rate of locoregional recurrence in a large series with clinical follow-up

Journal Article

Turashvili, G.; Brogi, E.; Morrow, M.; Dickler, M.; Norton, L.; Hudis, C.; Wen, H. Y.
BMC Cancer (2018)

Fulltext@MSK | Save

Surgical ovarian ablation for hormone receptor positive primary breast cancer in premenopausal women

Meeting Abstract

Oseledchyk, A.; Gemignani, M.; Dickler, M. N.; Goldfarb, S. B.; Iasonos, A.; Zhou, Q.; Carter, J.; Barakat, R. R.; Abu-Rustum, N.; Zivanovic, O.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials

Meeting Abstract

Martin, M.; Loibl, S.; Hyslop, T.; de la Haba-Rodriguez, J.; Aktas, B.; Cirrincione, C.; Carrasco, E. M.; Mehta, K.; Barry, W. T.; Morales, S.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy

Meeting Abstract

Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Extended adjuvant aromatase inhibitor therapy in post-menopausal women

Journal Article

Schleicher, S. M.; Dickler, M. N.
Current Breast Cancer Reports (2017)

Fulltext@MSK | Save

Genetic predisposition to bevacizumab-induced hypertension

Journal Article

Frey, M. K.; Dao, F.; Olvera, N.; Konner, J. A.; Dickler, M. N.; Levine, D. A.
Gynecologic Oncology (2017)

Fulltext@MSK | Save

Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy

Meeting Abstract

Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Analysis of overall survival by tumor response in MONARCH 1, a phase 2 study of abemaciclib, a CDK4 and CDK6 inhibitor, in women with HR+/HER2- metastatic breast cancer (MBC) after chemotherapy for advanced disease